Andrew Huberman· PhD
to my knowledge there are no human data yet exploring the use of p5p or other vitamin B6 derivatives or capergoline or things of that sort to reduce prolactin in a controlled standardized clinical trial kind of manner
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
to my knowledge there are no human data yet exploring the use of p5p or other vitamin B6 derivatives or capergoline or things of that sort to reduce prolactin in a controlled standardized clinical trial kind of manner
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
for that reason some people have started to explore the use of things like p5p which is essentially a metabolite of vitamin B6 which is known to suppress prolactin as a way to try and buffer some of that crash